Peripheral lymphocyte fluctuation as an indicator of severe immune‐related adverse events in patients treated with immune checkpoint inhibitors

AIM: Immune checkpoint inhibitors (ICIs) have proven to be effective treatments for various cancers, but can also elicit immune‐related adverse events (irAEs). Given that severe irAEs can be life‐threatening, biomarkers that can predict the occurrence of irAEs are of paramount importance. ICIs affec...

Descripción completa

Detalles Bibliográficos
Autores principales: Haraguchi, Masafumi, Nakao, Yasuhiko, Narita, Syouhei, Matsumoto, Kousuke, Fukushima, Masanori, Sasaki, Ryu, Honda, Takuya, Miuma, Satoshi, Miyaaki, Hisamitsu, Nakao, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225184/
https://www.ncbi.nlm.nih.gov/pubmed/36934436
http://dx.doi.org/10.1002/cam4.5816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225184/
https://www.ncbi.nlm.nih.gov/pubmed/36934436
http://dx.doi.org/10.1002/cam4.5816

Ejemplares similares